The Centers for Medicare and Medicaid Services announced Aug. 18 that it is ending federal Medicaid and Children’s Health Insurance Program funding for gender-transition procedures for minors, one of the most sweeping health policy changes of the current administration.
The decision affects coverage in state Medicaid programs nationwide, effectively forcing states to either absorb full costs with their own dollars or end coverage for the procedures. Millions of low-income children enrolled in Medicaid across all 50 states are potentially affected.
CMS framed the action as implementing a clear administration priority, according to the agency’s announcement. The change applies to federally reimbursed gender-transition procedures for children and youth enrolled in Medicaid and CHIP.
The policy is expected to generate near-certain legal challenges from states and advocacy groups. Several state attorneys general have signaled they would contest any effort to restrict gender-affirming care through federal funding mechanisms.
Medical associations including the American Academy of Pediatrics and the American Medical Association have supported access to gender-affirming care for minors under physician supervision, though the issue remains one of the most contested areas of pediatric medicine.
Conservative groups and several Republican governors have applauded the move, arguing that federal taxpayers should not fund procedures they described as experimental and irreversible for children.
The change ranks among the most consequential actions CMS has taken under the current administration, fundamentally altering insurance coverage for a category of care that has become a central flashpoint in American cultural and political debates.
States with large Medicaid populations, including California, New York, and Illinois, face the most significant fiscal impact if they choose to continue covering the procedures with state-only funds.